Tempus

Processes and analyzes genomic and molecular sequencing data to identify mutations, biomarkers, and genetic signatures relevant to cancer treatment. Integrates multi-omics datasets to create a comprehensive molecular profile of a patient's tumor.

Aggregates and normalizes diverse clinical data sources including electronic health records, pathology reports, imaging results, and treatment histories into a unified patient data model. Enables cross-referencing of clinical information with molecular findings.

Collects and analyzes real-world treatment outcomes and effectiveness data from clinical practice to supplement randomized trial evidence. Provides insights into how treatments perform in actual patient populations outside controlled trial settings.

Supports implementation of precision medicine protocols and workflows within healthcare institutions. Provides tools and guidance for integrating molecular testing, data analysis, and treatment recommendations into standard clinical practice.

Analyzes integrated patient data (molecular, clinical, imaging) to generate personalized treatment recommendations based on evidence from clinical trials, published literature, and institutional outcomes. Ranks treatment options by predicted efficacy and relevance to the patient's specific cancer profile.

Matches patient profiles against active clinical trial eligibility criteria to identify relevant trials where the patient may be enrolled. Considers molecular characteristics, clinical stage, prior treatments, and other inclusion/exclusion criteria.

Processes and interprets medical imaging data (CT, MRI, PET scans) to extract relevant features and measurements that inform treatment decisions. Integrates imaging findings with molecular and clinical data for comprehensive assessment.

Predicts likely treatment outcomes and survival probabilities based on patient molecular profile, clinical characteristics, and historical outcomes of similar patients. Provides prognostic information to guide treatment selection.

Aggregates and synthesizes relevant clinical literature, case reports, and published evidence related to a patient's specific cancer type and molecular profile. Provides curated evidence summaries to support clinical decision-making.

Predicts sensitivity or resistance of a patient's tumor to specific drugs based on molecular profile and known drug-mutation interactions. Identifies which therapies are most likely to be effective against the patient's specific cancer.

Compares a patient's characteristics and treatment outcomes against institutional historical data and benchmarks. Provides context on how similar patients have fared with different treatment approaches within the organization.

Provides comprehensive case summaries and decision support tools for tumor board discussions. Aggregates molecular, clinical, imaging, and evidence data into a structured format optimized for collaborative clinical decision-making.